Get the Stockscreener App
187.31
0.98%
-1.85
Davita Inc stock is traded at $187.31, with a volume of 505.38K.
It is down -0.98% in the last 24 hours and down -3.38% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$189.16
Open:
$189.28
24h Volume:
505.38K
Relative Volume:
1.01
Market Cap:
$11.95B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
17.98
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
+4.50%
1M Performance:
-3.38%
6M Performance:
+26.45%
1Y Performance:
+49.55%
1-Day Range:
$186.54
$189.91
1-Week Range:
$179.37
$189.91
52-Week Range:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, EHC, FMS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
187.31 | 11.95B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
458.84 | 99.34B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.25 | 21.52B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
127.87 | 12.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.17 | 11.80B | 22.44B | 1.35B | 2.03B | 1.9002 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-26 | Upgrade | TD Cowen | Hold → Buy |
| May-06-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
A Look at DaVita Inc (DVA) After 4.7% Gain -- GF Value $197.72 v - GuruFocus
Why patients miss dialysis is one focus of seven studies DaVita will present. - Stock Titan
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today - Zacks Investment Research
DaVita rated Buy with 22% upside, driven by agg... - Pluang
DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again (NYSE:DVA) - Seeking Alpha
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance
DaVita Inc Bills, 2006 - OpenSecrets
DaVita activates emergency plan to ensure dialy... - Pluang
DaVita Center Updates During Hurricane Isaias - DaVita Newsroom
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength? - Zacks Investment Research
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita stock enters October 23 report after Q2 earnings beat - AD HOC NEWS
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why - Zacks Investment Research
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why - Yahoo Finance
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is DaVita Stock Underperforming the S&P 500? - webull.com
DaVita stock heads into the open after September 24 loss - AD HOC NEWS
DaVita Inc (DVA) Shares Fall 4.6% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
DaVita stock heads into the open after a 0.55 percent gain - AD HOC NEWS
Is DaVita Stock Underperforming the S&P 500? - Yahoo Finance
Is DaVita Stock Underperforming the S&P 500? - inkl
DaVita stock holds above USD 183 as earnings estimates rise - AD HOC NEWS
DaVita (NYSE:DVA) Stock Forecast & Analyst Predictions - Simply Wall Street
DaVita Inc. stock slips 0.65 percent as earnings support outlook - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Uncovering a 19.58% Upside Within the Healthcare Sector - DirectorsTalk Interviews
DaVita Inc (DVA) Shares Fall 5.6% -- What GF Score of 91 Tells I - GuruFocus
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. stock advances as Q2 2026 earnings and guidance underpin strong valuation - ad-hoc-news.de
DaVita Community Care Report 2025: Our Journey to Net Zero - ACCESS Newswire
DaVita Community Care Report 2025: Our Journey to Net Zero - StreetInsider
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Davita Inc Stock (DVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Javier Rodgriguez | Officer |
Jun 16 '26 |
Proposed Sale |
209.28 |
39,407 |
8,247,016 |
0 |
| Rodriguez Javier | Chief Executive Officer |
Jun 16 '26 |
Sale |
209.28 |
39,407 |
8,247,018 |
840,408 |
| Kathleen Waters | Officer |
Jun 15 '26 |
Proposed Sale |
207.84 |
8,950 |
1,860,202 |
0 |
| Javier Rodriguez | Officer |
Jun 15 '26 |
Proposed Sale |
209.50 |
30,000 |
6,285,102 |
0 |
| Waters Kathleen Alyce | Officer |
Jun 15 '26 |
Proposed Sale |
207.93 |
6,455 |
1,342,188 |
0 |
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Jun 15 '26 |
Sale |
208.40 |
15,405 |
3,210,377 |
109,194 |
| Rodriguez Javier | Chief Executive Officer |
Jun 15 '26 |
Sale |
209.50 |
30,000 |
6,285,090 |
879,815 |
| HEARTY JAMES O | Chief Compliance Officer |
May 15 '26 |
Sale |
193.98 |
15,000 |
2,909,745 |
22,389 |
| James Hearty | Officer |
May 15 '26 |
Proposed Sale |
193.93 |
15,000 |
2,908,950 |
0 |
| HEARTY JAMES O | Chief Compliance Officer |
May 14 '26 |
Option Exercise |
110.63 |
5,784 |
639,884 |
41,737 |
0.18%
1.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):